Parkman Healthcare Partners’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $971K | Sell |
|
|||||
|
2023
Q2 | $2.01M | Buy |
|
|||||
|
2023
Q1 | $1.34M | Sell |
|
|||||
|
2022
Q4 | $3.89M | Buy |
|
|||||
|
2022
Q3 | $3.68M | Sell |
|
|||||
|
2022
Q2 | $4.26M | Sell |
|
|||||
|
2022
Q1 | $11.5M | Sell |
|
|||||
|
2021
Q4 | $14.9M | Sell |
|
|||||
|
2021
Q3 | $23.5M | Sell |
|
|||||
|
2021
Q2 | $26.4M | Sell |
|
|||||
|
2021
Q1 | $43.1M | Sell |
|
|||||
|
2020
Q4 | $12.1M | Buy |
|
|||||
|
2020
Q3 | $4.74M | Buy |
|
|||||
|
2020
Q2 | $2.75M | Buy |
|
|||||
|
2020
Q1 | $1.6M | Buy |
|
|||||
|
2019
Q4 | $425K | Buy |
|